Participation of pharmacists in clinical trial recruitment for low back pain

International Journal of Clinical Pharmacy

Volumn 36, Issue 5, 2014, Pages 986-994

  Abdel Shaheed, Christina ^a   Maher, Christopher G ^b,c   Williams, Kylie A ^d   McLachlan, Andrew J ^a,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^e ANZAC Research Institute   (Australia)

Author keywords

Clinical trials; Evidence based management; Low back pain; Pharmacist; Screening

Indexed keywords

DICLOFENAC; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RUBEFACIENT;

ADULT; ARTICLE; AUSTRALIA; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; LOW BACK PAIN; MALE; OPEN ENDED QUESTIONNAIRE; PARAMEDICAL EDUCATION; PHARMACIST; PRACTICE GUIDELINE; CONTROLLED CLINICAL TRIAL (TOPIC); HEALTH PERSONNEL ATTITUDE; PATIENT SELECTION; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CONTROLLED CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; LOW BACK PAIN; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PHARMACISTS; QUESTIONNAIRES;

EID: 84911427220     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-014-9985-y     Document Type: Article

References (32)

1. Silcock J, Moffett JK, Edmondson H, Waddell G, Burton AK. Do community pharmacists have the attitudes and knowledge to support evidence based self-management of low back pain? BMC Musculoskelet Disord. 2007;8:10.
2. Walker BF, Muller R, Grant WD. Low back pain in Australian adults. Health provider utilization and care seeking. J Manipulative Physiol Ther. 2004;27(5):327–35.
3. Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167–76.
4. Community pharmacists as an accelerant for clinical trial recruitment (2013). http://prod.mckesson.s3.amazonaws.com/pdf/McKessonStudyLinkWhitePaper.pdf. Accessed 28 June 2014.
5. Gul RB, Ali PA. Clinical trials: the challenge of recruitment and retention of participants. J Clin Nurs. 2010;19(1–2):227–33.
6. Williams C, Maher C, Hancock M, McAuley J, Lin C, Latimer J. Recruitment rate for a clinical trial was associated with particular operational procedures and clinician characteristics. J Clin Epidemiol. 2014;67(2):169–75.
7. Williams CM, Latimer J, Maher CG, McLachlan AJ, Cooper CW, Hancock MJ, et al. PACE—the first placebo controlled trial of paracetamol for acute low back pain: statistical analysis plan. Trials. 2013;14:248.
8. van Tulder M, Becker A, Bekkering T, Breen A, del Real MTG, Hutchinson A, et al. Chapter 3 European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J. 2006;15(Suppl 2):S169–91.
9. Australian Acute Musculoskeletal Pain Guidelines Group. Evidence-based management of acute musculoskeletal pain - A guide for clinicians. Australian Academic Press. Bowen Heads, Qld; 2004.
10. Koes BW, van Tulder M, Lin C-WC, Macedo LG, McAuley J, Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19(12):2075–94.
11. Davies RA, Maher CG, Hancock MJ. A systematic review of paracetamol for non-specific low back pain. Eur Spine J. 2008;17(11):1423–30.
12. Australian Institute of Health and Welfare: General Characteristics of persons involved in health and community services occupations. http://www.aihw.gov.au/publication-detail/?id=6442468220&tab=3Accessed July 2013.
13. Grant RW, Sugarman J. Ethics in human subjects research: Do incentives matter? J Med Philos. 2004;29(6):717–38.
14. Shere M, Zhao XY, Koren G. The role of social media in recruiting for clinical trials in pregnancy. PLoS One. 2014;9(3):e92744.
15. Lee SJ, Lenert L, Weisman S, Kavanaugh A. Factors affecting rheumatoid arthritis patients’ decisions to participate in clinical trials. J Rheumatol. 2005;32(12):2317–25.
16. Gifford F. Community-equipoise and the ethics of randomized clinical trials. Bioethics. 1995;9(2):127–48.
17. Kao LS, Aaron BC, Dellinger EP. Trials and tribulations: current challenges in conducting clinical trials. Arch Surg. 2003;138(1):59–62.
18. Williams CM, Maher CG, Latimer J, McLachlan AJ, Hancock MJ, Day RO, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;doi.10.1016/S0140-6736(08)61345-8.
19. Abdel Shaheed C, Maher CG, Williams KA, McLachlan AJ. Interventions available over the counter and advice for acute low back pain: systematic review and meta-analysis. J Pain. 2014;15(1):2–15.
20. Perrot S, Krause D, Crozes P, Naim C, Group G-Z-S. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study. Clin Ther. 2006;28(10):1592–606.
21. Rosner F. The ethics of randomized clinical trials. Am J Med. 1987;82(2):283–90.
22. Edwards S, Lilford R, Hewison J. The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals. BMJ. 1998;317(7167):1209–12.
23. Kaptchuk TJ, Shaw J, Kerr CE, Conboy LA, Kelley JM, Csordas TJ, et al. “Maybe I made up the whole thing”: placebos and patients’ experiences in a randomized controlled trial. Cult Med Psychiatry. 2009;33(3):382–411.
24. Foddy B. A duty to deceive: placebos in clinical practice. Am J Bioeth. 2009;9(12):4–12.
25. Justman S. From medicine to psychotherapy: the placebo effect. Hist Human Sci. 2011;24(1):95–107.
26. Barnhill A. Clinical use of placebos: still the physician’s prerogative? Hastings Cent Rep. 2012;42(3):29–37.
27. Henderson A, Winch S, Holzhauser K, De Vries S. The motivation of health professionals to explore research evidence in their practice: an intervention study. J Clin Nurs. 2006;15(12):1559–64.
28. Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr., Shekelle P et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. [Erratum appears in Ann Intern Med. 2008 Feb 5;148(3):247-8; PMID: 18257154], [Summary for patients in Ann Intern Med. 2007 Oct 2;147(7):I45; PMID: 17909203]. Ann Intern Med. 2007;147(7):478–491.
29. Henschke N, Maher CG, Refshauge KM, Herbert RD, Cumming RG, Bleasel J, et al. Prevalence of and screening for serious spinal pathology in patients presenting to primary care settings with acute low back pain. Arthritis Rheum. 2009;60(10):3072–80.
30. Williams CM, Henschke N, Maher CG, van Tulder MW, Koes BW, Macaskill P, et al. Red flags to screen for vertebral fracture in patients presenting with low-back pain. Cochrane Database Syst Rev. 2013;1:CD008643.
31. Henschke N, Maher CG, Refshauge KM. A systematic review identifies five “red flags” to screen for vertebral fracture in patients with low back pain. J Clin Epidemiol. 2008;61(2):110–8.
32. Jette N, Lix LM, Metge CJ, Prior HJ, McChesney J, Leslie WD. Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol. 2011;68(1):107–12.